Acarix presents at Naventus Health Care Summit 2022
Press release
Malmö, Sweden, May 6, 2022
Acarix presents at Naventus Health Care Summit 2022
Helen Ljungdahl Round, President and CEO of Acarix AB (publ), will present at the Naventus Health Care Summit in Stockholm on May 10, 2022.
Acarix is one of twelve leading companies within the Healthcare sector to present their views on the present trends in precision medicine and latest innovative technological developments in life science.
Acarix is at the forefront of AI-powered acoustic diagnostic technologies in cardiology. The novel CADScor®System is designed for rapid assessment in patients with stable chest pain and suspected CAD. Within 10 minutes, those with low risk can be ruled out with 96% certainty. Millions of people experience chest pain annually and many undergo lengthy diagnostic assessments. As many as 9 out of 10 are found to not have CAD, putting an unnecessary burden on the health care systems and patients. The CADScor®System has CE-marking and is commercially available in Europe. With the FDA De Novo clearance and reimbursement approval, the company is now entering a new expansion phase with the launch in the US.
This event is a perfect opportunity to learn about the latest market updates technological innovations within the Healthcare sector. The event is hosted by Naventus & Partners live from Spegelsalen, Grand Hôtel in Stockholm with opportunities to join virtually.
Learn more about Acarix and CADScor®System here.
Sign up for the event here.
For more information contact:
Helen Ljungdahl Round, CEO,phone +1 267 809 1225,+46 730 770283 helen.round@acarix.com
The information was provided, through the agency of the above contact person, for publication at the time specified by the company's news distributor, GlobeNewswire.
About Acarix:
Acarix is a Swedish medical device company that innovates solutions for rapid AI-based rule out of Coronary Artery Disease (CAD). The CE approved and FDA DeNovo cleared Acarix CADScor®System is intended for patients experiencing chest pain with suspected CAD and designed to help reduce millions of unnecessary, invasive and costly diagnostic procedures. The CADScor®System calculates a patient-specific CAD-score non-invasively in less than 10 minutes and can help rule out more than one third of patients with at least 96% certainty (in a population with approx. 10% CAD prevalence). Acarix is listed on the Nasdaq First North Premier Growth Market (ticker: ACARIX). Redeye AB (+46 (0)8 121 576 90, certifiedadviser@redeye.se) is Certified Advisor of Acarix. For more information, please visit www.acarix.com.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Decisions of Sampo plc’s Annual General Meeting25.4.2024 15:35:00 CEST | Press release
SAMPO PLC DECISIONS OF GENERAL MEETING 25 April 2024 at 4:35 pm Decisions of Sampo plc’s Annual General Meeting The Annual General Meeting of Sampo plc, held today on 25 April 2024, approved all the proposals made to the AGM by the Board of Directors and its Committees, including distribution of dividend of EUR 1.80 per share for 2023. The AGM adopted the financial accounts for 2023 and discharged the members of the Board of Directors and CEO from liability for the financial year ending 31 December 2023. The AGM authorised the Board of Directors to decide on share repurchases and a share issue without payment. Including proxy representatives, there were altogether 320,218,518 shares (63.8 per cent of shares) and 321,018,518 votes (63.9 per cent of all votes) in the company represented at the Annual General Meeting. Dividend payment The AGM decided to distribute a dividend of EUR 1.80 per share for 2023. The dividend will be paid to the shareholders registered in the Company’s sharehold
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)25.4.2024 15:30:00 CEST | Press release
ORION CORPORATION STOCK EXCHANGE RELEASE – MAJOR SHAREHOLDER ANNOUNCEMENTS 25 APRIL 2024 at 16.30 EEST Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has received a disclosure under Chapter 9, Section 5 of the Securities Market Act, according to which the total number of Orion shares owned directly, indirectly and through financial instruments by BlackRock, Inc. and its funds increased on 24 April 2024 above five (5) per cent of Orion Corporation’s total shares. Total positions of BlackRock, Inc. and its funds subject to notification: % of shares and voting rights (total of point A)% of shares and voting rights through financial instruments (total of point B)Total of both in % (points A + B)Total number of shares and voting rights of issuerResulting situation on the date on which threshold was crossed or reached4.99% shares Below 5% voting rights0.02% shares Below 5% voting rights5.01% shares Below 5% voting rig
Årsstämma PolyPlank AB (publ)25.4.2024 15:29:47 CEST | Pressemelding
PolyPlank AB (publ) har hållit årsstämma på Bolagets kontor, Färjestaden, Öland. Samtliga beslut fattades enligt styrelsens förslag fram till punkt 8c samt punkt 13 som flyttades fram före punkt 9. Punkt 9-12 ajournerades till fortsatt stämma att hållas den 13 juni 2024. Ny kallelse publiceras senast fyra veckor före den fortsatta stämman. Stämman beslutade att fastställa de i årsredovisningen intagna resultat- och balansräkningarna samt koncernresultaträkning och koncernbalansräkning.Stämman beslutade att behandla det uppkomna resultatet i enlighet med styrelsens förslag i årsredovisningen.Stämman beviljade styrelsens ledamöter och verkställande direktören ansvarsfrihet för förvaltningen under det gångna året.Stämman beslutade att enligt styrelsens förslag minska det registrerade aktiekapitalet för att ge större utrymme för att täcka förluster som inte täcks av fritt eget kapital. Minskning ska ske utan indragning av aktier. För ytterligare information, vänligen kontakta: Vd Marina Ab
Proceedings at the extraordinary general meeting on April 25, 202425.4.2024 15:27:01 CEST | Press release
Company announcement no 6-2024 Søborg, April 15, 2024 Proceedings at the extraordinary general meeting on April 25, 2024 An extraordinary general meeting of Konsolidator A/S took place on April 25, 2024 at Konsolidator A/S, Vandtårnsvej 83A, 2., DK-2860 Søborg, in accordance with the agenda. The board of directors elected Jakob Vig Schnack, attorney-at-law, as chairman of the meeting. The general meeting approved the only item on the agenda, which was the proposal by the board of directors to include a new authorization in the articles of association for the board of directors to increase the share capital with a nominal value of up to DKK 240,000 without pre-emption rights for the existing shareholders. The minutes of the extraordinary general meeting and the updated articles of association are available at www.konsolidator.com/investors/ and attached to this announcement. Contacts CEO: Claus Finderup Grove, mobile +45 2095 2988, cfg@konsolidator.comCFO: Jack Skov, mobile, +45 2282 88
A larger Hispack seeks to accelerate responsible packaging solutions25.4.2024 15:19:14 CEST | Press release
BARCELONA, Spain, April 25, 2024 (GLOBE NEWSWIRE) -- Hispack 2024 will focus on sustainable packaging to contribute to a better future. From May 7 to 10, Spain's largest packaging tradeshow will gather 780 exhibitors from 28 countries and 1,250 brands at Fira de Barcelona's Gran Via venue to showcase the latest innovations in materials, packaging, containers, labels, wrapping, processing, and logistics technology and machinery. Over 27,000 attendees are expected at the 2024 edition. Organized by Fira de Barcelona in collaboration with Graphispack Association, Hispack 2024 will grow by 18% in number of companies and 12% in exhibition space and will spread over 36,000 m2 in halls 2 and 3 featuring leading manufacturers and distributors with the latest technology, materials and packaging solutions focusing on sustainability. This event has also registered an increase in the number of international exhibitors, with almost a third of the total coming from outside Spain. Turkey will lead the